New role for plasmin in sodium homeostasis

Current Opinion in Nephrology and Hypertension

Volumn 19, Issue 1, 2010, Pages 13-19

  Passero, Christopher J ^a   Hughey, Rebecca P ^a,b   Kleyman, Thomas R ^a,b  

^a Renal Electrolyte Division   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Epithelial sodium channel; Kidney tubules; Plasmin; Plasminogen; Proteinuria

Indexed keywords

ALBUMIN; AMILORIDE; APROTININ; CREATININE; EPITHELIAL SODIUM CHANNEL; FURIN; PLASMIN; PLASMINOGEN; PROSTASIN; PROTEIN; SODIUM; UROKINASE;

ALBUMINURIA; BLOOD PRESSURE; CARBOXY TERMINAL SEQUENCE; CREATININE URINE LEVEL; EDEMA; ENZYME ACTIVATION; EXTRACELLULAR SPACE; FIBRINOLYSIS; GENE MUTATION; GLOMERULUS; HOMEOSTASIS; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; HYPERVOLEMIA; KIDNEY COLLECTING TUBULE; KIDNEY PARENCHYMA; LIDDLE SYNDROME; NEPHROSIS; NEPHROTIC SYNDROME; PRECIPITATION; PREDICTION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN URINE LEVEL; PROTEINURIA; REVIEW; SODIUM RETENTION; URINE;

ANIMALS; EDEMA; EPITHELIAL SODIUM CHANNEL; FIBRINOLYSIN; HOMEOSTASIS; HUMANS; HYPERTENSION; KIDNEY TUBULES; MICE; MODELS, BIOLOGICAL; MODELS, MOLECULAR; PROTEINURIA; SODIUM;

EID: 73849123580     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e3283330fb2     Document Type: Review

References (62)

1. Bhalla V, Hallows KR. Mechanisms of ENaC regulation and clinical implications. J Am Soc Nephrol 2008; 19:1845-1854.
2. Rossier BC, Pradervand S, Schild L, Hummler E. Epithelial sodium channel and the control of sodium balance: interaction between genetic and environmental factors. Annu Rev Physiol 2002; 64:877-897.
3. Deschenes G, Feraille E, Doucet A. Mechanisms of oedema in nephrotic syndrome: old theories and new ideas. Nephrol Dial Transplant 2003; 18:454-456.
4. Strazzullo P, Galletti F, Barba G. Altered renal handling of sodium in human hypertension: short review of the evidence. Hypertension 2003; 41:1000-1005.
5. Kleyman TR, Carattino MD, Hughey RP. ENaC at the cutting edge: regulation of epithelial sodium channels by proteases. J Biol Chem 2009; 284:20447-20451.
6. Lemann J Jr, Doumas BT. Proteinuria in health and disease assessed by measuring the urinary protein/creatinine ratio. Clin Chem 1987; 33:297-299.
7. Forman JP, Fisher ND, Schopick EL, Curhan GC. Higher levels of albuminuria within the normal range predict incident hypertension. J Am Soc Nephrol 2008; 19:1983-1988.
8. Hsu CY, Iribarren C, McCulloch CE, et al. Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med 2009; 169:342-350.
9. Lambers Heerspink HJ, Brantsma AH, de Zeeuw D, et al. Albuminuria assessed from first-morning-void urine samples versus 24-h urine collections as a predictor of cardiovascular morbidity and mortality. Am J Epidemiol 2008; 168:897-905.
10. Ninomiya T, Perkovic V, Verdon C, et al. Proteinuria and stroke: a metaanalysis of cohort studies. Am J Kidney Dis 2009; 53:417-425.
11. Agarwal R, Andersen MJ. Correlates of systolic hypertension in patients with chronic kidney disease. Hypertension 2005; 46:514-520. (Pubitemid 41376831)
12. Kim BJ, Lee HJ, Sung KC, et al. Comparison of microalbuminuria in 2 blood pressure categories of prehypertensive subjects. Circ J 2007; 71:1283-1287.
13. Feld LG, Brentjens JR, Van Liew JB. Renal injury and proteinuria in female spontaneously hypertensive rats. Ren Physiol 1981; 4:46-56.
14. Rossi GP, Bernini G, Desideri G, et al. Renal damage in primary aldosteronism: results of the PAPY study. Hypertension 2006; 48:232-238.
15. Wang G, Lai FM, Kwan BC, et al. Podocyte loss in human hypertensive nephrosclerosis. Am J Hypertens 2009; 22:300-306.
16. Inoue T, Iseki K, Higashiuesato Y, et al. Proteinuria as a significant determinant of hypertension in a normotensive screened cohort in Okinawa. Japan Hypertens Res 2006; 29:687-693.
17. Wang TJ, Gona P, Larson MG, et al. Multiple biomarkers and the risk of incident hypertension. Hypertension 2007; 49:432-438.
18. de Boer IH, Kestenbaum B, Rue TC, et al. Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus. Arch Intern Med 2008; 168:1867-1873.
19. Kastner C, Pohl M, Sendeski M, et al. Effects of receptor-mediated endocytosis and tubular protein composition on volume retention in experimental glomerulonephritis. Am J Physiol Renal Physiol 2009; 296:F902-F911.
20. Passero CJ, Mueller GM, Rondon-Berrios H, et al. Plasmin activates epithelial Na+ channels by cleaving the gamma subunit. J Biol Chem 2008; 283:36586-36591.
21. Svenningsen P, Bistrup C, Friis UG, et al. Plasmin in nephrotic urine activates the epithelial sodium channel. J Am Soc Nephrol 2009; 20:299-310.
22. Crew RJ, Radhakrishnan J, Appel G. Complications of the nephrotic syndrome and their treatment. Clin Nephrol 2004; 62:245-259.
23. Rasool A, Palevsky PM. Treatment of edematous disorders with diuretics. Am J Med Sci 2000; 319:25-37.
24. Doucet A, Favre G, Deschenes G. Molecular mechanism of edema formation in nephrotic syndrome: therapeutic implications. Pediatr Nephrol 2007; 22:1983-1990.
25. Usberti M, Gazzotti RM. Hyporeninemic hypoaldosteronism in patients with nephrotic syndrome. Am J Nephrol 1998; 18:251-255.
26. Vande Walle JG, Donckerwolcke RA, van Isselt JW, et al. Volume regulation in children with early relapse of minimal-change nephrosis with or without hypovolaemic symptoms. Lancet 1995; 346:148-152.
27. Ichikawa I, Rennke HG, Hoyer JR, et al. Role for intrarenal mechanisms in the impaired salt excretion of experimental nephrotic syndrome. J Clin Invest 1983; 71:91-103.
28. Schrier RW, Fassett RG. A critique of the overfill hypothesis of sodium and water retention in the nephrotic syndrome. Kidney Int 1998; 53:1111-1117.
29. Botero-Velez M, Curtis JJ, Warnock DG. Brief report: Liddle's syndrome revisited: a disorder of sodium reabsorption in the distal tubule. N Engl J Med 1994; 330:178-181.
30. Rotin D, Schild L. ENaC and its regulatory proteins as drug targets for blood pressure control. Curr Drug Targets 2008; 9:709-716.
31. Staub O, Verrey F. Impact of Nedd4 proteins and serum and glucocorticoidinduced kinases on epithelial Na+ transport in the distal nephron. J Am Soc Nephrol 2005; 16:3167-3174.
32. Vehaskari VM. Heritable forms of hypertension. Pediatr Nephrol 2007; 24:1929-1937.
33. Eaton DC, Malik B, Saxena NC, et al. Mechanisms of aldosterone's action on epithelial Na + transport. J Membr Biol 2001; 184:313-319.
34. Griffing GT, Cole AG, Aurecchia SA, et al. Amiloride in primary hyperaldosteronism. Clin Pharmacol Ther 1982; 31:56-61.
35. Verrey F. Early aldosterone action: toward filling the gap between transcription and transport. Am J Physiol 1999; 277:F319-F327.
36. Canessa CM, Merillat AM, Rossier BC. Membrane topology of the epithelial sodium channel in intact cells. Am J Physiol 1994; 267:C1682-C1690.
37. Snyder PM, McDonald FJ, Stokes JB, Welsh MJ. Membrane topology of the amiloride-sensitive epithelial sodium channel. J Biol Chem 1994; 269: 24379-24383.
38. Chraibi A, Vallet V, Firsov D, et al. Protease modulation of the activity of the epithelial sodium channel expressed in Xenopus oocytes. J Gen Physiol 1998; 111:127-138.
39. Vuagniaux G, Vallet V, Jaeger NF, et al. Synergistic activation of ENaC by three membrane-bound channel-activating serine proteases (mCAP1, mCAP2, and mCAP3) and serum- and glucocorticoid-regulated kinase (Sgk1) in Xenopus oocytes. J Gen Physiol 2002; 120:191-201.
40. Adebamiro A, Cheng Y, Rao US, et al. A segment of gamma ENaC mediates elastase activation of Na+ transport. J Gen Physiol 2007; 130:611-629.
41. Caldwell RA, Boucher RC, Stutts MJ. Neutrophil elastase activates near-silent epithelial Na+ channels and increases airway epithelial Na+ transport. Am J Physiol Lung Cell Mol Physiol 2005; 288:L813-L819.
42. Garcia-Caballero A, Dang Y, He H, Stutts MJ. ENaC proteolytic regulation by channel-activating protease 2. J Gen Physiol 2008; 132:521-535.
43. Harris M, Firsov D, Vuagniaux G, et al. A novel neutrophil elastase inhibitor prevents elastase activation and surface cleavage of the epithelial sodium channel expressed in Xenopus laevis oocytes. J Biol Chem 2007; 282:58-64.
44. Hughey RP, Bruns JB, Kinlough CL, et al. Epithelial sodium channels are activated by furin-dependent proteolysis. J Biol Chem 2004; 279:18111-18114.
45. Picard N, Eladari D, El Moghrabi S, et al. Defective ENaC processing and function in tissue kallikrein-deficient mice. J Biol Chem 2008; 283:4602-4611.
46. Caldwell RA, Boucher RC, Stutts MJ. Serine protease activation of near-silent epithelial Na+ channels. Am J Physiol Cell Physiol 2004; 286:C190-C194.
47. Firsov D, Schild L, Gautschi I, et al. Cell surface expression of the epithelial Na channel and a mutant causing Liddle syndrome: a quantitative approach. Proc Natl Acad Sci U S A 1996; 93:15370-15375.
48. Hughey RP, Bruns JB, Kinlough CL, Kleyman TR. Distinct pools of epithelial sodium channels are expressed at the plasma membrane. J Biol Chem 2004; 279:48491-48494.
49. Sheng S, Carattino MD, Bruns JB, et al. Furin cleavage activates the epithelial Na+ channel by relieving Na+ self-inhibition. Am J Physiol Renal Physiol 2006; 290:F1488-F1496.
50. Bruns JB, Carattino MD, Sheng S, et al. Epithelial Na+ channels are fully activated by furin- and prostasin-dependent release of an inhibitory peptide from the gamma-subunit. J Biol Chem 2007; 282:6153-6160.
51. Hughey RP, Mueller GM, Bruns JB, et al. Maturation of the epithelial Na+ channel involves proteolytic processing of the alpha- and gamma-subunits. J Biol Chem 2003; 278:37073-37082.
52. Carattino MD, Sheng S, Bruns JB, et al. The epithelial Na+channel is inhibited by a peptide derived from proteolytic processing of its alpha subunit. J Biol Chem 2006; 281:18901-18907.
53. Diakov A, Bera K, Mokrushina M, et al. Cleavage in the {gamma}-subunit of the epithelial sodium channel (ENaC) plays an important role in the proteolytic activation of near-silent channels. J Physiol 2008; 586: 4587-4608.
54. Carattino MD, Hughey RP, Kleyman TR. Proteolytic processing of the epithelial sodium channel gamma subunit has a dominant role in channel activation. J Biol Chem 2008; 283:25290-25295.
55. Maarouf AB, Sheng N, Chen J, et al. Novel determinants of epithelial sodium channel gating within extracellular thumb domains. J Biol Chem 2009; 284:7756-7765.
56. Lau SO, Tkachuck JY, Hasegawa DK, Edson JR. Plasminogen and antithrombin III deficiencies in the childhood nephrotic syndrome associated with plasminogenuria and antithrombinuria. J Pediatr 1980; 96:390-392.
57. Vaziri ND, Gonzales EC, Shayestehfar B, Barton CH. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome. J Lab Clin Med 1994; 124:118-124.
58. Kristensen P, Eriksen J, Dano K. Localization of urokinase-type plasminogen activator messenger RNA in the normal mouse by in situ hybridization. J Histochem Cytochem 1991; 39:341-349.
59. Muellbacher W, Maier M, Binder BR. Regulation of plasminogen activation in isolated perfused rat kidney. Am J Physiol 1989; 256:F787-F793.
60. Piedagnel R, Tiger Y, Lelongt B, Ronco PM. Urokinase (u-PA) is produced by collecting duct principal cells and is posttranscriptionally regulated by SV40 large-T, arginine vasopressin, and epidermal growth factor. J Cell Physiol 2006; 206:394-401.
61. Eaton DC, Pooler JP. Renal functions, anatomy, and basic processes. In: Vander's renal physiology. 6th ed. New York: McGraw-Hill; 2004. p. 17 [Figures 1-7].
62. Vallet V, Chraibi A, Gaeggeler HP, et al. An epithelial serine protease activates the amiloride-sensitive sodium channel. Nature 1997; 389: 607-610.